SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):March 8, 2004
ELI LILLY AND COMPANY
(Exact name of registrant as specified in its charter)
| | | | | |
Indiana
(State or Other Jurisdiction
of Incorporation) | | 001-06351
(Commission
File Number) | | 35-0470950
(I.R.S. Employer
Identification No.) |
| | | | | |
Lilly Corporate Center
Indianapolis, Indiana
(Address of Principal
Executive Offices) | | | | 46285
(Zip Code) |
Registrant’s telephone number, including area code: (317) 276-2000
No Change
(Former name or former address, if changed since last report)
TABLE OF CONTENTS
Item 9. Regulation FD Disclosure
Eli Lilly and Company (the “Company”) is furnishing to the Commission its 2003 audited consolidated financial statements and management’s discussion and analysis. The Company is participating in an investor conference at which the above financial information has been made available. The Company intends to file its Form 10-K for 2003 and mail to its shareholders the 2003 annual report to shareholders and proxy statement on or about March 12, 2004. The information is furnished as Exhibit 99.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | ELI LILLY AND COMPANY
(Registrant)
| |
| | By: | /s/ Arnold C. Hanish | |
| | | Name: | Arnold C. Hanish | |
| | | Title: | Chief Accounting Officer | |
| |
Dated: March 9, 2004
EXHIBIT INDEX
| | | |
Exhibit Number
| | Exhibit
|
| 99 | | Audited Consolidated Financial Statements and Management’s Discussion and Analysis |
